Industry Opposes Idea Of New FDA Inspection Authority, Fee At House Hearing

Several device industry representatives told lawmakers on Capitol Hill May 14 that additional FDA user fees and expansion of pre-approval inspection authority to include less risky, Class II devices should not be part of a proposed bill making its way through Congress. They got support from the Republican members of the panel

More from Archive

More from Medtech Insight